...Okay. Great. Thanks, everybody, for joining us. Good afternoon, and welcome to Guggenheim's Fourth Annual Oncology Conference and today's fireside chat discussion with Eli Lilly. I'm Seamus Fernandez, Guggenheim's global biopharma analyst. I'm joined by Jake Van Naarden, President of Lilly Oncology; and Dr. David Hyman, Chief Medical Officer of Lilly Oncology. Jake, David, thanks so much for joining us here today....